Cargando…

A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab: A case of crosstalk between coagulation and complement?

RATIONALE: This article describes a child with a life-threatening multiorgan failure with disseminated intravascular coagulation (DIC) and massive complement consumption. To our knowledge this therapeutic approach was for the first time effectively applied in a pediatric patient. PATIENT CONCERNS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galic, Slobodan, Csuka, Dorottya, Prohászka, Zoltán, Turudic, Daniel, Dzepina, Petra, Milosevic, Danko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358330/ https://www.ncbi.nlm.nih.gov/pubmed/30681570 http://dx.doi.org/10.1097/MD.0000000000014105

Ejemplares similares

A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review
por: Turudic, Daniel, et al.
Publicado: (2022)

The Rationale of Complement Blockade of the MCP(ggaac) Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review
por: Turudic, Daniel, et al.
Publicado: (2023)

Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
por: Kelen, Dorottya, et al.
Publicado: (2021)

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014)

A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY
por: Trutin, Ivana, et al.
Publicado: (2021)

Role of Complement in Multiorgan Failure
por: Rittirsch, Daniel, et al.
Publicado: (2012)

Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation—etiological and therapeutic issues
por: Turudic, Daniel, et al.
Publicado: (2023)

The case of complement activation in COVID-19 multiorgan impact
por: Noris, Marina, et al.
Publicado: (2020)

Vascular Dementia and Crosstalk Between the Complement and Coagulation Systems
por: Mossanen Parsi, Milad, et al.
Publicado: (2021)

Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation
por: Heal, Samantha L., et al.
Publicado: (2022)

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R
por: Cserhalmi, Marcell, et al.
Publicado: (2017)

Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report
por: Abe, Tomohiro, et al.
Publicado: (2017)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus
por: Barkai, László József, et al.
Publicado: (2019)

Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
por: Gómez Delgado, Irene, et al.
Publicado: (2021)

Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
por: Milošević, Danko, et al.
Publicado: (2014)

Complement activation and effect of eculizumab in scleroderma renal crisis
por: Devresse, Arnaud, et al.
Publicado: (2016)

Eculizumab treatment alters the proteometabolome beyond the inhibition of complement
por: Nelke, Christopher, et al.
Publicado: (2023)

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
por: Acosta-Medina, Aldo A., et al.
Publicado: (2022)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
por: Pollack, Shirley, et al.
Publicado: (2021)

Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
por: Matošević, Matija, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
por: Torres, Everardo Arias, et al.
Publicado: (2021)

Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series
por: Burwick, Richard M., et al.
Publicado: (2022)

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
por: Laurence, Jeffrey, et al.
Publicado: (2020)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021)

Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems
por: Berkowitz, Shani, et al.
Publicado: (2021)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
por: Trojnar, Eszter, et al.
Publicado: (2019)

Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
por: Aigner, Christof, et al.
Publicado: (2020)

Complement and coagulation cascades in trauma
por: Satyam, Abhigyan, et al.
Publicado: (2019)

Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report
por: Nakamura, Masahiko, et al.
Publicado: (2022)

Commentary: Hematuria as an early sign of multisystem inflammatory syndrome in children: A case report of a boy with multiple comorbidities and a review of the literature
por: Adasevic, Boris, et al.
Publicado: (2022)

Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2021)

Editorial: Complement and COVID-19 Disease
por: Prohászka, Zoltán, et al.
Publicado: (2022)

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
por: Sinkovits, György, et al.
Publicado: (2021)

Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
por: Aigner, Christof, et al.
Publicado: (2021)

The first case of paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome treated with complement inhibitor eculizumab in Korea
por: Kim, Hyerim, et al.
Publicado: (2017)

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19
por: Leone, Valentina Fanny, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ub8iqhkdd44fc98eq56n5hkra